Leukemia Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments.

Learn more about participating in a clinical trial at Norton Healthcare.

Acute Myeloid Leukemia (AML)

A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of AG-120 in Combination with Azacitidine in Subjects ? 18 Years of Age with Previously Untreated Acute Myeloid Leukemia with an IDH1 Mutation

Acute Myeloid Leukemia (AML)

Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of CPI-613 in Combination with High Dose Cytarabine and Mitoxantrone (CHAM) Compared to High Dose Cytarabine and Mitoxantrone (HAM) in Older Patients (? 60 […]

Chronic Lymphocytic Leukemia (CLL)

A Multi-Center, Open-Label, Study to Evaluate the Safety and Efficacy of Ublituximab (TG-1101) in Combination with TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304

Chronic Lymphocytic Leukemia (CLL)

A Randomized, Multicenter, Open-Label, Phase 3 Study to Compare the Efficacy and Safety of Acalabrutinib (ACP-196) in Combination with Venetoclax with and without Obinutuzumab Compared to Investigator’s Choice of Chemoimmunotherapy in Subjects with Previously Untreated […]

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Leukemia

A Phase III, Double-Blind, Placebo-Controlled, Multicenter, Randomized Study of Pracinostat in Combination with Azacitidine in Patients ?18 Years with Newly Diagnosed Acute Myeloid Leukemia unfit for Standard Induction Chemotherapy

Leukemia

A Multicenter, Open-Label Phase 1b Study to Assess Safety and Efficacy of Venetoclax in Combination with Gilteritinib in Subjects with Relapsed/Refractory Acute Myeloid Leukemia.

Lymphoma

A PHASE 1/2A OPEN-LABEL, MULTI-DOSE, MULTI-CENTER ESCALATION AND EXPLORATORY STUDY OF CERDULATINIB(PRT062070) IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL) OR B-CELL or T-CELL NON-HODGKIN LYMPHOMA (NHL)

Myeloproliferative Neoplasms

SL-401 in Patients With Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Primary Eosinophilic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)

Cancer – 4673

Appointments

Cancer care that isn’t too far from home.

(502) 629-HOPE (4673)


Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3501

Art therapist’s breast cancer journey fuels passion to help others with the disease

While Leigh Galloway undergoes her last chemotherapy treatment before a double mastectomy, she and Laura Chamberlin are engrossed in a watercolor. Like she does often with Laura, an expressive art therapist with Norton Cancer Institute […]

Read Full Story

Pathology lab provides expertise in cancer and other conditions

Patients don’t see pathologists, but these physicians can make all the difference when it comes to diagnosing and treating cancer and other conditions, said Alvin W. Martin, M.D., medical director for Norton Healthcare’s CPA Lab. [...]

Read Full Story

Bringing new gynecologic cancer treatments and caring for patients like family

After working as an obstetrician/gynecologist for five years, Charles B. Palmer, D.O., was drawn to patients needing complex care. He decided to become a gynecologic oncologist, diagnosing and treating cancers in women’s reproductive organs. “The [...]

Read Full Story

Bike to Beat Cancer raises more than $525,000 for Norton Cancer Institute

Riders, donors and everyone who participated in the 11th annual Bike to Beat Cancer raised more than $525,000 for Norton Cancer Institute. The Saturday, Sept. 14, ride began and ended at Norton Cancer Institute – […]

Read Full Story

An oncologist with a passion for people and leading-edge science

Chandler H. Park, M.D., knew he wanted to travel to get his medical education, but he also knew he’d find his way back home. Dr. Park’s education and clinical experience have taken him to the […]

Read Full Story
Related Stories

Art therapist’s breast cancer journey fuels passion to help others with the disease

While Leigh Galloway undergoes her last chemotherapy treatment before a double mastectomy, she and Laura Chamberlin are engrossed in a watercolor. Like she does often with Laura, an expressive art therapist with Norton Cancer Institute […]

Read Full Story

Pathology lab provides expertise in cancer and other conditions

Patients don’t see pathologists, but these physicians can make all the difference when it comes to diagnosing and treating cancer and other conditions, said Alvin W. Martin, M.D., medical director for Norton Healthcare’s CPA Lab. [...]

Read Full Story

Bringing new gynecologic cancer treatments and caring for patients like family

After working as an obstetrician/gynecologist for five years, Charles B. Palmer, D.O., was drawn to patients needing complex care. He decided to become a gynecologic oncologist, diagnosing and treating cancers in women’s reproductive organs. “The [...]

Read Full Story

Bike to Beat Cancer raises more than $525,000 for Norton Cancer Institute

Riders, donors and everyone who participated in the 11th annual Bike to Beat Cancer raised more than $525,000 for Norton Cancer Institute. The Saturday, Sept. 14, ride began and ended at Norton Cancer Institute – […]

Read Full Story

An oncologist with a passion for people and leading-edge science

Chandler H. Park, M.D., knew he wanted to travel to get his medical education, but he also knew he’d find his way back home. Dr. Park’s education and clinical experience have taken him to the […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.